Aura Biosciences Stock Investor Sentiment

AURA Stock  USD 7.42  0.12  1.59%   
About 80 percent of Aura Biosciences' investors are selling. The analysis of the overall investor sentiment regarding Aura Biosciences suggests that a fairly large number of traders are terrified. The current market sentiment, together with Aura Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Aura Biosciences stock news signals to limit their universe of possible portfolio assets.
  

Aura Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aura Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at thelincolnianonline.com         
Aura Biosciences, Inc. Given Average Recommendation of Buy by Brokerages
news
over a week ago at finance.yahoo.com         
Aura Appoints Thomas Clayton Chief Operating Officer and President
Yahoo News
over two weeks ago at finance.yahoo.com         
Aura Intelligence Redefines the Future of AI-Driven Workforce Intelligence with a Game-Changing Plat...
Yahoo News
over two weeks ago at globenewswire.com         
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder...
Macroaxis News: globenewswire.com
over two weeks ago at finance.yahoo.com         
Aura Unites with Boston Childrens Hospital to Address the Role of Technology in the Crisis of Wellbe...
Yahoo News
over two weeks ago at news.google.com         
How Will Aura Biosciences Address Investors at Two Major Healthcare Conferences Next Month - StockTi...
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Aura Biosciences, Inc. SVP Sells 10,881.00 in Stock
news
over three weeks ago at www.macroaxis.com         
Disposition of 20221 shares by De Los Pinos Elisabet of Aura Biosciences at 7.7541 subject to Rule 1...
Macroaxis News
over a month ago at newswire.com         
Clear Capitals Appraisal Underwriting Risk Analyzer, AURA, now Available Through ICE Mortgage Techno...
news
over a month ago at finance.yahoo.com         
Clear Capitals Appraisal Underwriting Risk Analyzer, AURA, now Available Through ICE Mortgage Techno...
Yahoo News
over a month ago at finance.yahoo.com         
Companies Like Aura Biosciences Are In A Position To Invest In Growth
Yahoo News
over a month ago at thelincolnianonline.com         
Q1 Earnings Forecast for AURA Issued By Leerink Partnrs
news
over a month ago at news.google.com         
How to Take Advantage of moves in - Stock Traders Daily
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Amy Elazzouzi of 29760 shares of Aura Biosciences at 7.68 subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
Aura Biosciences, Inc. Short Interest Update
news
Far too much social signal, news, headlines, and media speculation about Aura Biosciences that are available to investors today. That information is available publicly through Aura media outlets and privately through word of mouth or via Aura internal channels. However, regardless of the origin, that massive amount of Aura data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aura Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aura Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aura Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aura Biosciences alpha.

Aura Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Trading Advice - Stock Traders Daily
01/02/2025
2
Disposition of 1001 shares by Amy Elazzouzi of Aura Biosciences at 7.6715 subject to Rule 16b-3
01/21/2025
3
FY2024 Earnings Forecast for AURA Issued By Lifesci Capital
01/24/2025
4
Acquisition by Mattessich Antony C. of 10500 shares of Aura Biosciences subject to Rule 16b-3
01/27/2025
5
Acquisition by Amy Elazzouzi of 29760 shares of Aura Biosciences at 7.68 subject to Rule 16b-3
02/03/2025
6
How to Take Advantage of moves in - Stock Traders Daily
02/04/2025
7
Clear Capitals Appraisal Underwriting Risk Analyzer, AURA, now Available Through ICE Mortgage Technologys Encompass Platform
02/13/2025
8
Disposition of 20221 shares by De Los Pinos Elisabet of Aura Biosciences at 7.7541 subject to Rule 16b-3
02/18/2025
9
Aura Biosciences, Inc. SVP Sells 10,881.00 in Stock
02/19/2025
10
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 4...
03/03/2025
11
Aura Biosciences, Inc. Given Average Recommendation of Buy by Brokerages
03/17/2025

Complementary Tools for Aura Stock analysis

When running Aura Biosciences' price analysis, check to measure Aura Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aura Biosciences is operating at the current time. Most of Aura Biosciences' value examination focuses on studying past and present price action to predict the probability of Aura Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aura Biosciences' price. Additionally, you may evaluate how the addition of Aura Biosciences to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets